These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 16616242

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.
    Gayle RB, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, Brasel K, Price V, Drosopoulos JH, Islam N, Alyonycheva TN, Broekman MJ, Marcus AJ.
    J Clin Invest; 1998 May 01; 101(9):1851-9. PubMed ID: 9576748
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
    Degen H, Borst O, Ziegler M, Mojica Munoz AK, Jamasbi J, Walker B, Göbel S, Fassbender J, Adler K, Brandl R, Münch G, Lorenz R, Siess W, Gawaz M, Ungerer M.
    J Am Heart Assoc; 2017 Jul 27; 6(8):. PubMed ID: 28751543
    [Abstract] [Full Text] [Related]

  • 13. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model.
    Buergler JM, Maliszewski CR, Broekman MJ, Kaluza GL, Schulz DG, Marcus AJ, Raizner AE, Kleiman NS, Ali NM.
    J Thromb Thrombolysis; 2005 Apr 27; 19(2):115-22. PubMed ID: 16052302
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.
    Hyman MC, Petrovic-Djergovic D, Visovatti SH, Liao H, Yanamadala S, Bouïs D, Su EJ, Lawrence DA, Broekman MJ, Marcus AJ, Pinsky DJ.
    J Clin Invest; 2009 May 27; 119(5):1136-49. PubMed ID: 19381014
    [Abstract] [Full Text] [Related]

  • 16. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
    Köhler D, Eckle T, Faigle M, Grenz A, Mittelbronn M, Laucher S, Hart ML, Robson SC, Müller CE, Eltzschig HK.
    Circulation; 2007 Oct 16; 116(16):1784-94. PubMed ID: 17909107
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
    Dwyer KM, Robson SC, Nandurkar HH, Campbell DJ, Gock H, Murray-Segal LJ, Fisicaro N, Mysore TB, Kaczmarek E, Cowan PJ, d'Apice AJ.
    J Clin Invest; 2004 May 16; 113(10):1440-6. PubMed ID: 15146241
    [Abstract] [Full Text] [Related]

  • 19. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
    Castilhos LG, Doleski PH, Adefegha SA, Becker LV, Ruchel JB, Leal DB.
    Biomed Pharmacother; 2016 Apr 16; 79():241-6. PubMed ID: 27044834
    [Abstract] [Full Text] [Related]

  • 20. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
    Kaneider NC, Egger P, Dunzendorfer S, Noris P, Balduini CL, Gritti D, Ricevuti G, Wiedermann CJ.
    Arterioscler Thromb Vasc Biol; 2002 Jun 01; 22(6):894-900. PubMed ID: 12067895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.